Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Myriad Receives FDA Approval of BRACAnalysis CDx(TM) as Companion Diagnostic for Lynparza(TM) (olaparib) in Ovarian Cancer Patients

GlobeNewswire December 19, 2014

M2M Market Opportunities and Solutions: Ecosystem Analysis, Leading Applications, and Security Challenges

PR Newswire December 19, 2014

Bina Technologies is acquired by Roche.

PR Newswire December 19, 2014

Roche acquires Bina Technologies and enters the genomic informatics market

PR Newswire December 19, 2014

The Global In-Situ Hybridization Market is Expected to Grow at a CAGR of 11.7% from 2014 to 2019

PR Newswire December 19, 2014

Wounds Therapeutic Pipeline H2 2014 Review in New Market Research Report

PR Newswire December 19, 2014

Georgia Bio Deals of the Year Spotlight Financings, Acquisitions and Collaboration

Business Wire December 19, 2014

Research and Markets: Russia Surgical Sutures Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, B. Braun Melsungen and Covidien

Business Wire December 19, 2014

Son of a Mesothelioma Victim Shows Veterans with Mesothelioma How to Get the Right Answers, Right Away

PR Newswire December 19, 2014

Janssen Receives Positive CHMP Opinion Recommending VELCADE® (bortezomib) for use in Mantle Cell Lymphoma

PR Newswire December 19, 2014

Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study

Canada NewsWire December 19, 2014

Tekmira Pharmaceuticals Announces Leadership Changes

GlobeNewswire December 19, 2014

PreventionGenetics Teams Up With Seattle Children's Hospital PLUGS Program to Enhance Utilization Management

GlobeNewswire December 19, 2014

Three Somagenics Publications Demonstrate Successful Inhibition of the Hepatitis C Virus by Therapeutic sshRNA(TM) and Confirm Mechanism of Action

PR Newswire December 19, 2014

Soligenix Announces Pricing of Public Offering of Units

PR Newswire December 19, 2014

Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant

Business Wire December 19, 2014

HOT TOPIC: Ebola Outbreak

Business Wire December 19, 2014

Atossa Genetics Inc. Provides Update on Pharmacogenetics Testing Now Offered by The National Reference Laboratory for Breast Health, Inc.

Marketwired December 19, 2014

OncoGenex Announces Results from the Phase 2 Borealis-1(TM) Trial of Apatorsen in the Treatment of Metastatic Bladder Cancer

Canada NewsWire December 19, 2014

Translarna Granted Orphan Drug Designation in the U.S. and Europe for the Treatment of Mucopolysaccharidosis I

PR Newswire December 19, 2014